Kenya has approved confined field trials for a gene-edited banana developed to resist Banana Xanthomonas Wilt (BXW), a destructive bacterial disease that continues to threaten banana production across East Africa.

The approval, granted by the National Biosafety Authority (NBA), allows researchers from the International Institute of Tropical Agriculture (IITA) and the Kenya Agricultural and Livestock Research Organization (KARLO) to begin testing the banana under local farming conditions to assess its disease resistance, yield potential and adaptability.

The decision marks a significant milestone for Kenya’s agricultural biotechnology sector, as the crop becomes the country’s first locally developed gene-edited crop to be approved as a conventional product rather than a genetically modified organism (GMO).

According to researchers leading the project, the banana was developed using genome-editing technology that modifies the plant’s existing genetic material without introducing foreign DNA from other organisms. As a result, regulators determined that the crop does not meet the classification of a GMO under Kenya’s current biosafety framework.

Addressing a Major Threat to Banana Production

Banana Xanthomonas Wilt is caused by the bacterium Xanthomonas campestris pv. musacearum and is one of the most damaging diseases affecting banana and plantain crops in East Africa.

The disease disrupts water movement within the plant, causing leaves to wilt and dry out. Infected fruits often ripen prematurely, become discoloured and lose their market value. In severe cases, entire plantations can be destroyed if outbreaks are not contained.

BXW spreads through infected planting materials, contaminated farming tools, insects that visit banana flowers and the movement of infected plant tissues between farms.

Current management practices require farmers to uproot infected plants, disinfect tools, remove male buds and use disease-free planting materials. While effective, these measures are labour-intensive, costly and often difficult for smallholder farmers to maintain consistently.

Potential Benefits for Farmers

Researchers believe the gene-edited banana could provide a more sustainable and affordable solution to controlling the disease.

The upcoming field trials will generate critical data on disease resistance, productivity and environmental performance before any future commercial release is considered.

If successful, the technology could help farmers reduce crop losses, improve productivity and strengthen food security in regions where bananas serve as both a staple food and an important source of household income.

Kenya Strengthens Leadership in Agricultural Biotechnology

The approval further reinforces Kenya’s position as a regional leader in agricultural biotechnology and genome-editing research.

In recent years, the country has supported research and innovation aimed at addressing agricultural challenges such as pests, crop diseases and climate-related production risks. Biotechnology initiatives involving maize, cotton and cassava have already formed part of broader efforts to improve agricultural productivity and resilience.

Experts say gene-editing technologies could play an increasingly important role in developing crop varieties that are more resistant to disease, drought and other production constraints, helping farmers adapt to changing agricultural conditions.

As the field trials begin, Kenya’s gene-edited banana project is expected to provide valuable insights into the future role of advanced breeding technologies in strengthening food security and supporting sustainable agricultural development across Africa.